Adjuvant Radiotherapy Clinical Trials
4 recruitingRadiation
Phase 23Phase 31
Showing 1–4 of 4 trials
Recruiting
Phase 3
Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Locally Advanced Head and Neck Squamous Cell Carcinoma
Ming-Yuan Chen430 enrolled1 locationNCT07524452
Recruiting
Phase 2
Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Locally Advanced Head and Neck Squamous Cell Carcinoma
Xiwei XU22 enrolled1 locationNCT07371234
Recruiting
Phase 2
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial
Breast Cancer
M.D. Anderson Cancer Center300 enrolled1 locationNCT06897488
Recruiting
Phase 2
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Breast Cancer
Xijing Hospital27 enrolled2 locationsNCT06914440